| Project Name | Project Stage | Molecule Type | Molecule Source | Disease Area | Indication |
|---|---|---|---|---|---|
| CLDN6 mAb - 01 | PCC | Monoclonal | Humanized Mouse | Solid Tumor | Ovarian cancer,Lung adenocarcinoma |
| English Name | Research Code | Highest Development Stage | Company | Indication | Clinical Trial |
|---|---|---|---|---|---|
| QLS-5132 | QLS5132; QLS-5132 | Phase 2 Clinical | Qilu Pharmaceutical Co Ltd | Carcinoma, Non-Small-Cell Lung; Endometrial Neoplasms; Ovarian Neoplasms; Solid tumours; Stomach Neoplasms | Details |
| TORL-1-23 | TORL-1-23 | Phase 2 Clinical | Torl Biotherapeutics LLC | Carcinoma, Non-Small-Cell Lung; Carcinoma, Ovarian Epithelial; Endometrial Neoplasms; Fallopian Tube Diseases; Fallopian Tube Neoplasms; Ovarian Neoplasms; Peritoneal Diseases; Peritoneal Neoplasms; Solid tumours | Details |
| PLB-002 | PLB-002; PLB002 | Phase 1 Clinical | PrimeLink BioTherapeutics | Endometrial Neoplasms; Ovarian Neoplasms; Solid tumours; Testicular Neoplasms | Details |
| BGB-B455 | BGB-B455 | Phase 1 Clinical | BeOne Medicines Ltd | Solid tumours | Details |
| AT03-65 | AT-03-65; AT03-65 | Phase 1 Clinical | Axcynsis Therapeutics Pte Ltd | Solid tumours | Details |
| ARC-101 | ARC101; ARC-101 | Phase 1 Clinical | Third Arc Bio Inc | Endometrial Neoplasms; Lung Neoplasms; Ovarian Neoplasms; Solid tumours | Details |
| CTIM-76 | CTIM-76 | Phase 1 Clinical | Integral Molecular Inc | Endometrial Neoplasms; Neoplasms; Ovarian Neoplasms; Solid tumours; Testicular Neoplasms | Details |
| NBL-028 | NBL028; NBL-028 | Phase 1 Clinical | Novarock Biotherapeutics Ltd, Shanghai Xinshi Biological Medicine Co Ltd | Carcinoma, Non-Small-Cell Lung; Endometrial Neoplasms; Neoplasms; Ovarian Neoplasms; Solid tumours; Stomach Neoplasms; Testicular Neoplasms | Details |
| XmAb-541 | XmAb541; XmAb-541 | Phase 1 Clinical | Xencor Inc | Endometrial Neoplasms; Germinoma; Neoplasms, Germ Cell and Embryonal; Ovarian germ cell tumor; Ovarian Neoplasms | Details |
| SAIL-66 | SAIL66; SAIL-66 | Phase 1 Clinical | Chugai Pharmaceutical Co Ltd | Solid tumours | Details |
| CLDN6-CAR-NK Cell Therapy | Phase 1 Clinical | Second Affiliated Hospital Of Guangzhou Medical University | Endometrial Neoplasms; Ovarian Neoplasms | Details | |
| TJ-C64B | TJ-C64B | Phase 1 Clinical | I-Mab Biopharma Co Ltd | Ovarian Neoplasms; Stomach Neoplasms | Details |
| CLDN6 CAR-T cell therapy (BioNTech) | BNT-211 | Phase 1 Clinical | Biontech Se | Germinoma; Neoplasms, Gonadal Tissue; Solid tumours; Testicular Neoplasms | Details |